Biomimetic lung sealant to rapidly heal pulmonary air leaks, decrease recovery time, and reduce healthcare costs.
Unmet Medical Need: There is no current effective lung sealant available, leaving a significant gap in therapeutic options to treat post-surgical pulmonary air leaks, despite the high risk, incidence, and cost of these pulmonary air leaks
Envisioned Healthcare Product: A biomimetic sealant made of lung extracellular matrix with aerated alveolar-like pores and endogenous regenerative growth factors that effectively seals air leaks within 15 seconds and bioactively supports lung tissue healing, thereby reducing recovery time, postoperative complications and health carecosts, and improving outcomes for patients recovering from lung surgery and thoracic trauma.
Stage of Development: Proof of Concept
Funding Cycle: 2019-2020